Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Three Additional Centers Begin Clinical Testing of Multikine ALEXANDRIA, Va., Sept. 18, 1996 -- CEL-SCI Corporation (Nasdaq: CELI) today announced that three additional medical institutions will participate in the clinical testing of an experimental new anti-cancer drug developed by CEL-SCI Corporation. Wayne State University, Detroit, Michigan; The Sir Mortimer B. Davis Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada and Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada will assume active roles in testing Multikine, a drug composed of a natural mixture of cytokines, or human immune system modulating proteins. Multikine will be tested in up to thirty advanced head and neck cancer patients who have previously failed treatment. The Phase I-II clinical trial will be an open label, randomized, dose-ranging study that is designed to assess optimum dose, safety, tumor response, and immune system response in patients receiving multiple courses of the drug. The study is designed to confirm positive findings made in an earlier study. Cancer patients who wish to know whether they are eligible to participate in the clinical trial may contact CEL-SCI Corporation at 703-549-5293 to be referred to coordinators at the appropriate centers. CEL-SCI Corporation is a pioneer in the field of natural immunotherapy. It is developing Multikine for the treatment of cancers and other immunodeficiency diseases. In addition, it is developing the HGP-30 HIV vaccine/treatment and a tuberculosis vaccine/treatment. E-mail this page to a friend or colleague! To print, use this version